RE:"Altercyte or Overcyte" EDTXF, the "PINK Planter" ......I guess, even the most gifted (those in the top 90% of all analysts), occassionally do make mistakes. Like forgetting the main exchange a stock trades on, or what the price target is.
What is that 0.6 Analyst ranking mean ? Does that mean he is rated at 6/10ths of 1 out of 10?
I thought it might be the ratio of the current SP to the Anlayst Target Price, but that's .15 (or for those that prefer fractions, about 1/7th)
It's a shame (sp sham?) that no other analysts want to be apart of a Biotech/medical device developer, involved in two very LATE stage Trials, each addressing unmet needs (for decades) in two multi-BILLION dollar markets. Especially when the Trial results are "exceeding expectations", whilst one at least, is in "confirmatory" and "3b" mode.
MM